|Tuesday, May 31, 2011|
|Assoc. Prof. Stuart Peacock and colleagues receive $4.7 million to study early-stage oral cancer|
|Researchers from UBC’s Faculties of Medicine, Science and Dentistry—including School of Population and Public Health Assoc. Prof. Stuart Peacock—are leading a $4.7 million pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral squamous cell cancers. Funded by the Terry Fox Research Institute, the Canadian Optically Guided Approach for Oral Lesions Surgical Trial, or COOLS Study, involves universities and hospitals in nine Canadian cities. Findings from the study could revolutionize clinical practice here and around the world.|
Dr. Peacock will be leading the health economics component of the trial, with Ian Cromwell and Sonya Cressman from the Canadian Centre for Applied Research in Cancer Control (ARCC). This component of the research will look at the cost-effectiveness of new optical guided techniques for surgery in Oral Cancer.
Read the full UBC news release for more details.
|Monday, May 30, 2011|
|CHSPR to match Robert G. Evans Legacy Fund dollar for dollar|
|The UBC Centre for Health Services and Policy Research (CHSPR) will match dollar for dollar the funding for the new Robert G. Evans Legacy Fund. Dr. Evans has taught health economics to generations of SPPH and the former Dept. of Health Care and Epidemiology grad students. He is a Faculty member in CHSPR and an internationally esteemed health economist, who has received numerous accolades, including the Order of Canada. His groundbreaking work extends from health economics, through health care policy and comparative financing systems, to the social determinants of health. |
CHSPR has established a series of awards to continue Bob’s legacy and to advance leadership in the field. This Fund will support bursaries for new trainees and visiting lectureships by internationally-recognized researchers whose work is advancing our understanding of health care system organization and financing. To learn more and donate to the fund, visit the Supporting UBC website.
|Thursday, May 26, 2011|
|WorkSafeBC-CHSPR Partnership Renewed|
|WorkSafeBC's Board of Directors has approved the renewal of funding for the WorkSafeBC-CHSPR Partnership, led by Drs. Mieke Koehoorn and Chris McLeod. The Partnership has been renewed for a 5-year term for a total of $1.3 million. More information on the program and its key research findings are found at the partnership website.|
|Thursday, May 26, 2011|
|Congratulations to SPPH’s spring 2011 graduates|
|Forty-three School of Population and Public Health students graduated in yesterday’s UBC spring congregation. The Master of Public Health (MPH) program’s 24 students included Aditi Amin, Caitlin Blewett, Janice Bridgland, Lauren Brown, Jennifer Campbell, Jacquelyn Cragg, Carmen Dyck, Joanne Edwards, Ladan Hamadani, Kendra Jones, Miranda Kelly, Emily Laflamme, Daniela Meier, Brian Ng, Lyndsay O’Hara, Jayaram Pai, Georgios Papadopoulos, Neda Razaz Rahmati, Michelle Reid, Neetu Shukia, John Taylor, Kira Tozer, Despina Tzemis, and Andrea Wilson. The six Master of Health Administration (MHA) students graduating were Sara Atallah, Julia Barnscher, Victoria Brown, Rebecca Dunham, Karen Salamat, and Danielle. Wilson. Master of Health Science (MHSc) graduates were Ahmad Imam, Marcela Sanchez, and Kimberly Morishita. Graduating from the Master of Science (MSc) program were Rod Knight, Rebecca Haber, Ya-Wen Yu, and Renuka Grover. PhD students included Ahmed Abdel Rahim, Kathleen Deering, Francois Dionne, Anne Harris, Brandon Marshall, and Meghan Winters. |
Check out the feature story on MPH student Miranda Kelly in UBC Reports’ congregation issue: A passion for health care policy.
SPPH hosted an afternoon tea celebration for the graduates and their families. View photos from the event.
|Thursday, May 19, 2011|
|Canada could save about $1.3B a year if it had Ontario generic drug pricing: CHSPR study|
|Assist. Prof. Michael Law and colleagues at the Centre for Health Services and Policy Research have released a report recommending provinces consider changes to their generic drug prices and the use of more competitive bulk purchasing policies based on the Ontario model.|
In July 2010, the province of Ontario enacted a policy that halved reimbursement for generic drugs from the public drug plan, and substantially lowered prices for private purchases. The research team estimates that total expenditure on generic drugs in Ontario during the second half of 2010 was between $181 and $194 million below what would be expected if prices had remained at pre-policy level. The study found that if Ontario’s pricing scheme were adopted nationally, overall spending on generic drugs in Canada would drop at least $1.28 billion annually—a 5 per cent decrease in total prescription drug expenditure.
Read more and download the report on the CHSPR website.
Check out some of the media coverage of this study.
|Wednesday, May 18, 2011|
|Audio & presentation available for special rounds presentation on Healthcare Associated Infections|
|The School of Population and Public Health hosted a special grand rounds presentation on May 17 by Dr. William Jarvis, MD, titled "Mandatory reporting of healthcare associated infections: Can U.S. experience inform Canadian policy?" |
Listen to the presentation (MP3 file) and view the PowerPoint presentation (PDF).
William Jarvis is an acknowledged world leader in hospital-acquired (nosocomial) infection control. He is a highly published expert in infectious diseases, infection control, epidemiology, public health, and pediatrics and has been a leader in infection control for over 20 years. He has been President of The Society for Healthcare Epidemiologists of America and was on the Board of Directors for the Association for Professionals in Infection Control Research Foundation. He currently serves on the U.S. Food and Drug Administration’s General Hospital and Personal Use Devises Committee. He has investigated and published over 150 hospital outbreaks, supervised and was an author on many of the current infection control guidelines,
conducted hundreds of epidemiologic studies, and trained over 50 Epidemic Intelligence Officers at the U.S. Centers for Disease Control and Prevention (CDC). He spent over 22 years at CDC in leadership positions in infection control and is considered one of the world’s experts in this area. He currently works as a consultant for Jason and Jarvis Associates and is a Fellow of the Infectious Diseases Society of America and the Society for Healthcare Epidemiologists of America.
|Tuesday, May 17, 2011|
|CHSPR study reveals ethnic differences in the use of prescription drugs in Canada|
|There are significant differences in prescription drug use between ethnic groups in Canada, according to a study by School of Population and Public Health Assoc. Prof. Steve Morgan, published online today in Open Medicine. Dr. Morgan, who is also the Associate Director of the UBC Centre for Health Services and Policy Research (CHSPR), and his co-authors found the biggest differences were seen for antidepressants. Chinese women, in particular, were half as likely as white women to fill prescriptions for antidepressants. They were also less likely to use antihypertensives, antibiotics and respiratory drugs.|
The findings suggest that cultural beliefs about health and treatment influence prescription drug use. They also suggest that healthcare practitioners need to keep ethnic and gender differences in mind when prescribing.
The study team including CHSPR researchers Gillian Hanley and Colleen Cunningham, along with colleague Hude Quan, compared the use of six classes of medications—antihypertensives, oral antibiotics, antidepressants, statins, respiratory drugs and nonsteroidal anti-infammatory drugs (NSAIDS)—among 19,270 urban, non-Aboriginal residents of British Columbia in 2005. Respondents were classified as white, Chinese, South Asian, Other Asian, mixed ethnicity or non-Asian, non-white. The researchers adjusted for age, health status, socio-economic factors and recent immigration.
Other findings from the study include:
The study was funded by an operating grant from the Canadian Institutes of Health Research. The construction of the research database was supported in part by contributions of the BC Ministry of Health Services to CHSPR.
South Asian men were more likely than white men to fill prescriptions for antibiotics
- Chinese men were less likely than white men to fill prescriptions for statins
- South Asian women and men were more likely than white women and men to fill prescriptions for NSAIDS
- Differences between ethnic groups were greater among women than men
View the full-text version of this article on Open Medicine